Advanced search
Publication Cover
Pragmatic and Observational Research Volume 13, 2022 - Issue
Submit an article Journal homepage
407
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Characterisation of the Australian Adult Population Living with Asthma: Severe - Exacerbation Frequency, Long-Term OCS Use and Adverse Effects

Kerry L Hancock1 Chandlers Hill Surgery, Happy Valley, SA, 5159, AustraliaView further author information
,
Sinthia Bosnic-Anticevich2 Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, 2006, Australia;3 Woolcock Institute of Medical Research, Glebe, MSW, 2037, Australia;4 Sydney Local Health District, Camperdown, NSW, 2050, AustraliaORCID Iconhttps://orcid.org/0000-0001-5077-8329View further author information
ORCID Icon,
John D Blakey5 Respiratory Medicine, Sir Charles Gairdner Hospital, Hospital Ave, Nedlands, WA, 6009, Australia;6 Curtin University Medical School, Bentley, Western Australia, 6102, AustraliaView further author information
,
Mark Hew7 Allergy, Asthma & Clinical Immunology, Alfred Health, Melbourne, VIC, 3004, Australia;8 Public Health and Preventive Medicine, Monash University, Victoria, 3800, AustraliaView further author information
,
Li Ping Chung9 Fiona Stanley Hospital, 11 Robin Warren Dr, Murdoch, WA, 6150, AustraliaView further author information
,
Biljana Cvetkovski3 Woolcock Institute of Medical Research, Glebe, MSW, 2037, AustraliaView further author information
,
Scott Claxton10 Genesis Care Sleep and Respiratory, Joondalup, WA, 6027, AustraliaView further author information
,
Peter Del Fante11 Hutt Street General Practice, Adelaide, SA, 5000, AustraliaView further author information
,
Eve Denton7 Allergy, Asthma & Clinical Immunology, Alfred Health, Melbourne, VIC, 3004, Australia;8 Public Health and Preventive Medicine, Monash University, Victoria, 3800, AustraliaView further author information
,
Joe Doan12 HealthPlus Medical Centre, Kogarah, NSW, 2217, AustraliaView further author information
,
Kanchanamala Ranasinghe13 School of Medicine, Griffith University, Nathan, QLD, Australia;14 Cannon Hill Family Doctors, Cannon Hill, QLD, 4170, AustraliaView further author information
,
Lucy Morgan15 Sydney Medical School, University of Sydney, Sydney, NSW, Australia;16 Department of Thoracic Medicine, Concord Hospital, Sydney, NSW, Australia;17 Australian School of Advanced Medicine, Macquarie University, Sydney, NSW, AustraliaView further author information
,
Anita Sharma18 Platinum Medical Centre, Chermside, QLD, 4032, AustraliaView further author information
,
Peter K Smith19 Griffith University, Southport, QLD, AustraliaView further author information
,
Deb Stewart20 Adjunct Lecturer, School of Medicine, University of Tasmania, Churchill Ave, Hobart, TAS, 7005, AustraliaView further author information
,
Philip J Thompson21 The Lung Health Clinic, Hollywood Medical Centre, Nedlands, 6009, Australia;22 The University of Western Australia, Perth, Western Australia, 6009, Australia;23 Curtin University, Bentley, Western Australia, 6102, AustraliaView further author information
,
Russell Wiseman24 Suncoast Medical Centre, Coolum Beach, QLD, 4573, AustraliaView further author information
,
John W Upham25 Diamantina Institute & PA-Southside Clinical Unit, the University of Queensland, Woolloongabba, QLD, 4102, AustraliaORCID Iconhttps://orcid.org/0000-0002-0017-3433View further author information
ORCID Icon,
Kwok Y Yan26 Department of Respiratory Medicine, W, Camperdown, NSW, 2050, AustraliaView further author information
,
Victoria Carter27 Optimum Patient Care, Cambridgeshire, CB24 3BA, UKView further author information
,
Kiranjeet Dhillon28 Optimum Patient Care Australia, Brisbane, QLD, 4000, AustraliaView further author information
,
Florian Heraud28 Optimum Patient Care Australia, Brisbane, QLD, 4000, AustraliaORCID Iconhttps://orcid.org/0000-0002-9584-1843View further author information
ORCID Icon,
Thao Le27 Optimum Patient Care, Cambridgeshire, CB24 3BA, UKView further author information
,
Rebecca Vella28 Optimum Patient Care Australia, Brisbane, QLD, 4000, AustraliaORCID Iconhttps://orcid.org/0000-0001-5221-3524View further author information
ORCID Icon,
David Price27 Optimum Patient Care, Cambridgeshire, CB24 3BA, UK;28 Optimum Patient Care Australia, Brisbane, QLD, 4000, Australia;29 Observational and Pragmatic Research Institute, Midview City, 573969, Singapore;30 Centre of Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Aberdeen, AB25 2ZD, UKCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-9728-9992View further author information
ORCID Icon & On behalf of the OPCA Improving Asthma outcomes in Australia Research Group show all
Pages 43-58 | Published online: 05 Jul 2022

References

  • Maddox L, Schwartz DA. The pathophysiology of asthma. Annu Rev Med. 2002;53:477–498. doi:10.1146/annurev.med.53.082901.103921
  • Australian Institute of Health and Welfare. Asthma Cat no ACM 38. Canberra: AIHW; 2021 Available from: https://www.aihw.gov.au/reports/chronic-respiratory-conditions/asthma-monitoring-based-on-current-indicators/contents/indicators. Accessed June 23, 2022.
  • To T, Stanojevic S, Moores G, et al. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health. 2012;12:204. doi:10.1186/1471-2458-12-204
  • Australian Institute of Health and Welfare. 2017. Emergency department care 2016–17: Australian hospital statistics. Health services series no. 80. Cat. no. HSE 194. Canberra: AIHW.
  • Thompson PJ, Salvi S, Lin J, et al. Insights, attitudes and perceptions about asthma and its treatment: findings from a multinational survey of patients from 8 Asia-Pacific countries and Hong Kong. Respirology. 2013;18::957–967. doi:10.1111/resp.12137
  • McDonald VM, Hiles SA, Godbout K, et al. Treatable traits can be identified in severe asthma registry and predict future exacerbations. Respirology. 2019;24:37–47. doi:10.1111/resp.13389
  • Australian Institute of Health and Welfare. Asthma Cat no ACM 33. Canberra: AIHW; 2021 Available from: https://www.aihw.gov.au/reports/chronic-respiratory-conditions/asthma/contents/deaths. Accessed June 23, 2022.
  • Chung LP, Upham JW, Bardin PG, Hew M. Rational oral corticosteroid use in adult severe asthma: a narrative review. Respirology. 2020;25:161–172. doi:10.1111/resp.13730
  • Price DB, Trudo F, Voorham J, et al. Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study. J Asthma Allergy. 2018;11:193–204. PMID: 30214247; PMCID: PMC6121746. doi:10.2147/JAA.S176026
  • Sullivan PW, Ghushchyan VH, Globe G, Schatz M. Oral corticosteroid exposure and adverse effect in asthmatic patients. J Allergy Clin Immunol. 2018;141:110–116. doi:10.1016/j.jaci.2017.04.009
  • Global Initiative for Asthma. The global strategy for asthma management and prevention; 2020 Available from: http://www.globalasthmareport.org. Accessed June 23, 2021.
  • Price D, Fletcher M, van der Molen T. Asthma control and management in 8000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey. Prim Care Respir Med. 2014;24:14009. doi:10.1038/npjpcrm.2014.9
  • Price D, David-Wang A, Cho SH, et al. On behalf of the REcognise Asthma and LInk to Symptoms and Experience (REALISE) Asia Working Group. Time for a new language for asthma control: results from REALISE Asia. J Asthma Allergy. 2015;8:93–103. doi:10.2147/JAA.S82633
  • Reddel HK, Sawyer SM, Everett PW, Flood PV, Peters MJ. Asthma control in Australia: a cross-sectional web-based survey in a nationally representative population. Med J Aust. 2015;202:492–498. doi:10.5694/mja14.01564
  • Bloom CI, Nissen F, Douglas IJ, et al. Exacerbation risk and characterisation of the UK’s asthma population from infants to old age. Thorax. 2018;73:313–320. doi:10.1136/thoraxjnl-2017-210650
  • Baptist AP, Busse PJ. Asthma over the age of 65: all’s well that ends well. J Allergy Clin Immunol. 2018;6:764–773.
  • D’Amato G, Vitale C, Molino A, et al. Asthma-related deaths. Multidiscip Respir Med. 2016;11:37. doi:10.1186/s40248-016-0073-0
  • National Asthma Council. Asthma and COPD medications; 2020. Available from: https://d8z57tiamduo7.cloudfront.net/resources/NAC-Asthma-COPD-Meds-Chart-November-2020-Web.pdf. Accessed September 22, 2021.
  • Ryan D, Heatley H, Heaney LG, et al. Potential severe asthma hidden in UK primary care. J Allergy Clin Immunol Pract. 2021;9:1612–1623. doi:10.1016/j.jaip.2020.11.053
  • Price D, Menzies-Gow A, Bachert C, et al. Association between a type 2 inflammatory disease burden score and outcomes among patients with asthma. J Asthma Allergy. 2021;29:1173–1183. doi:10.2147/JAA.S321212
  • Australian Bureau of Statistics. 2016. The Australian statistical geography standard (ASGS) remoteness structure. Available from: https://www.abs.gov.au/websitedbs/d3310114.nsf/home/remoteness+structure. Accessed June 3, 2021.
  • Suruki RY, Daugherty JB, Boudiaf N, Albers FC. The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA. BMC Pulm Med. 2017;17:74. doi:10.1186/s12890-017-0409-3
  • Blakey JD, Price DB, Pizzichini E, et al. Identifying risk of future asthma attacks using UK medical record data: a Respiratory Effectiveness Group Initiative. J Allergy Clin Immunol Pract. 2017;5:1015–1024. doi:10.1016/j.jaip.2016.11.007
  • Azzi EA, Kritikos V, Peters MJ, et al. Understanding reliever overuse in patients purchasing over-the counter short-acting beta2 agonists: an Australian community pharmacy based survey. BMJ Open. 2019;9:e028995. doi:10.1136/bmjopen-2019-028995
  • Fardet L, Petersen I, Nazareth I. Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 years. Rheumatology. 2011;50:1982–1990. doi:10.1093/rheumatology/ker017
  • Bleecker ER, Menzies-GOW AN, Price DB, et al. Systematic literature review of systemic corticosteroid use for asthma management. Am J Respir Crit Care Med. 2020;201:276–293. doi:10.1164/rccm.201904-0903SO
  • Sweeny J, Patterson CC, Menzies-Gow A, et al. on behalf of the British Thoracic Society Difficult Asthma Network. Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the optimum patient care research database and the British thoracic difficult asthma registry. Thorax. 2016;71:339–346. doi:10.1136/thoraxjnl-2015-207630
  • Tan R, Cvethovski B, Kritikos V, et al. Management of allergic rhinitis in the community pharmacy: identifying the reasons behind medication self-selection. Pharm Pract. 2018;16:1332. doi:10.18549/PharmPract.2018.03.1332
  • Bosnic-Anticevich S, Kritikos V, Carter V, et al. Lack of asthma and rhinitis control in general practitioner-managed patients prescribed fixed dose combination therapy in Australia. J Asthma. 2017;55:684–694. doi:10.1080/02770903.2017.1353611
  • Clatworthy J, Price D, Ryan D, Haughney J, Horne R. The value of self-reported assessment of adherence, rhinitis and smoking in relation to asthma control. Prim Care Respir Med. 2009;18:300–305. doi:10.4104/pcrj.2009.00037
  • Price D, Kemp L, Sims E, et al. Observational study comparing intranasal mometasone furoate with oral antihistamines for rhinitis and asthma. Prim Care Respir Med. 2010;19:266–273. doi:10.4104/pcrj.2010.00040
  • Lohia S, Schlosser RJ, Soler ZM. Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis. Allergy. 2013;68:569–579. doi:10.1111/all.12124
  • National Asthma Council. 2021. Australian Asthma Handbook. Available from: https://www.asthmahandbook.org.au/management/adults. Accessed June 3, 2021.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.